Intelligence · Patents
Patents expiring in 2027
Annual patent cliff calendar for 2027 — US pharmaceutical patents by expiration date.
- Patents
- 599
Quick answer
599 indexed pharmaceutical patents have expiration dates in 2027. Browse by soonest expiry with links to assignee companies and related drugs.
-
US 7220419
Self-assembling recombinant papillomavirus capsid proteins
granted -
US 7220730
Cancer specific radiolabeled conjugates regulated by the cell cycle for the treatment and diagnosis of cancer
granted -
US 7220745
Heterocyclic compounds useful to treat HCV
granted -
US 7220757
Compositions and methods for topical administration of 2-NH-heteroarylimidazoles
granted -
US 7220726
Antifungal pimaricin compositions and therapeutic methods employing same
granted -
US 7220853
Inhibition of chronic myelogenous leukemic cell growth by liposomal-antisense oligodeoxy-nucleotides targeting to Grb2 or Crk1
granted -
US 7220852
Coronavirus isolated from humans
granted -
US 7220582
Stem cells that transform to beating cardiomyocytes
granted -
EP 1786431
VERBESSERTE PHOTOSENSITIZERFORMULIERUNGEN UND DEREN VERWENDUNG
granted -
US 7223406
Methods and compositions for preventing and treating male erectile dysfunction and female sexual arousal disorder
granted -
US 7223836
Peptides for chlamydophila pneumoniae vaccine and diagnosis
granted -
US 7223787
Prenylation inhibitors reduce host cell permissiveness to viral replication
granted -
US 7223783
Indolinone derivatives
granted -
US 7223388
Modified reoviral therapy
granted -
US 7223726
Apolipoprotein A-I mutant proteins having cysteine substitutions and polynucleotides encoding same
granted -
US 7223571
Targeted glycosaminoglycan polymers by polymer grafting and methods of making and using same
granted -
US 7223380
Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging
granted -
US 7223424
Compositions and methods for prostate and kidney health and disorders, an herbal preparation
granted -
US 7223791
Function regulator for retinoid relative receptor
granted -
US 7223844
Broadly cross-reactive neutralizing antibodies against human immunodeficiency virus selected by Env-CD4-co-receptor complexes
granted -
US 7223853
Secreted frizzled related protein fragments
granted -
US 7223803
Polyethylene (glycol) derivatives with proximal reactive groups
granted -
US 7223563
Fibroblast growth factor (FGF23) nucleic acids
granted -
US 7223585
Viral purification methods
granted -
US 7227009
MT-SP1 polynucleotides and polypeptides
granted -
US 7227011
Nucleic acid vaccines for prevention of flavivirus infection
granted -
US 7226946
Substituted phenol compounds useful for anesthesia and sedation
granted -
US 7226602
Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses
granted -
US 7226588
Non-toxic mutants of pathogenic gram-negative bacteria
granted -
US 7226609
Sodium dodecyl sulfate compositions for inactivating prions
granted -
US 7226597
Mutants of Clostridium difficile toxin B and methods of use
granted -
US 7226920
Aminotriazole compounds useful as inhibitors of protein kinases
granted -
US 7226950
Sodium channel modulators
granted -
US 7226991
Phenylalanine derivatives
granted -
US 7227010
Recombinant light chains of botulinum neurotoxins and light chain fusion proteins for use in research and clinical therapy
granted -
US 7226589
Treatment of diseases by site specific instillation of cells or site specific transformation of cells and kits therefor
granted -
US 7226937
Methods for modulating phototoxicity
granted -
US 2007128117
Ultrasound contrast agents and process for the preparation thereof
granted -
US 7230086
Assay for YKL-40 as a marker for degradation of mammalian connective tissue matrices
granted -
US 7229995
Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
granted -
US 7230004
Cyclopamine analogues and methods of use thereof
granted -
US 7229986
Melanin-concentrating hormone antagonist
granted -
US 7229972
3,6-Bicyclolides
granted -
US 7229627
Apparatuses and methods for the production of haematophagous organisms and parasites suitable for vaccine production
granted -
US 7229963
Methods of using deacetylase inhibitors to promote cell differentiation and regeneration
granted -
US 7229641
Rapid-melt compositions methods of making same and methods of using same
granted -
US 7229770
YKL-40 as a marker and prognostic indicator for cancers
granted -
US 7229604
Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging
granted
Frequently asked questions
How many pharma patents expire in 2027?
599 published patents in our USPTO index have expiration dates falling in calendar year 2027.